In continuation of my update on "antisense drugs"....
Isis receives $5M milestone payment from GSK for initiating ISIS-TTRRx Phase 1 study
Isis receives $5M milestone payment from GSK for initiating ISIS-TTRRx Phase 1 study
Med-Chemist : "Quintessential Medicinal Chemistry"
No comments:
Post a Comment